Low- and middle-income countries (LMIC) currently experience low testing coverage in the face of increasing demand to meet the needs of millions of people living with HIV, TB, HPV, hepatitis and other diseases. Therefore, innovative solutions are urgently needed to enable a robust, efficiently utilised testing capacity, and a healthy and secure market with competitive supply.

ASLM is excited to host the diagnostic pricing database on behalf of the Integrated Diagnostics Consortium. Led by the Clinton Health Access Initiative, with funding from Unitaid, this pricing database initially focuses on automated molecular testing solutions offered to LMICs, to bring greater clarity and transparency to supplier pricing. The format of the pricing database is meant to facilitate a comparison of supplier pricing and offerings across crucial components of test procurement, including commodities, logistics, service and key product features. The pricing database, accessible below, will be updated biannually or when new information becomes available to reflect the latest changes in the market.

The pricing information below was last updated in December 2022. There is new pricing available that will be updated in the coming weeks.

Diagnostic Pricing 1

wdt_ID Company Platforms Corresponding assays Access pricing - Volume commitment Access pricing - Price per test (USD) Access pricing - Incoterm Access pricing - Instrument purchased or placed Access pricing - Price per instrument, if purchased (USD) Agreement specifications - Time commitment Agreement specifications - Eligible countries Laboratory - Reagents and proprietary consumables Laboratory - Invalid results due to instrument errors Laboratory - Non-proprietary consumables Laboratory - Instrument placement Laboratory - Service and maintenance (S&M) Laboratory - S&M fee per instrument (if not included in price) Supply chain for tests - Distributor and local agent fees Supply chain for tests - Packaging Supply chain for tests - Loading from warehouse Supply chain for tests - Pre-carriage Supply chain for tests - Export customs clearance Supply chain for tests - Handling at departure Supply chain for tests - Main transportation Supply chain for tests - Transportation insurance Supply chain for tests - Handling at arrival Supply chain for tests - Post-carriage Supply chain for tests - Duties and local taxes Supply chain for tests - Import customs clearance Supply chain for tests - Unloading at destination Additional resources and references
Click To View Full Screen

Diagnostic Pricing 2

wdt_ID Company Platforms Photo of platform Integrated kit/ separate reagents Batch controls Instrument portability Level of automation Max daily throughput inlcuding controls (Tests/8hr; 24hr) Sample loading Sample processing Time to first result (hrs)
Click To View Full Screen

*Multiple RT-PCR modules independently process cartridges

*The analyzer performs any requested sample in any sequence

Supplier Contact Information

Cepheid: Rachel O’Shea, Vice President, Global Access (Email)
Abbott: Francesco Marinucci, Director, Global Market Access & Funding (Email)
Roche: Joni Zurawinski, Sr PM, Business Development & Strategy (Email)
Hologic: Tiffany Clarke, Director, Marketing Virology and Global Health (Email)

Additional Resources & References

1

All prices for Abbott, Cepheid and Roche are indicative; small variations are possible based on the individual components in any given order.

2

Abbott mPima pricing: The exact price point within the range provided will depend on the combination of existing instruments (which were purchased) and new instruments (which will be placed), as well as whether the existing instruments are under warranty.

3

Instrument placement assumes utilizing in-country molecular infrastructure and placing additional equipment only if volumes justify doing so.

4

Other incoterms are possible at additional cost, please contact Cepheid directly.

5

This is a ceiling price associated with the volume commitment outlined above; lower prices may be accessed on a country-by-country basis, depending on number of placements, total testing volume, cost of access care, and other conditions.

6

Applicable only to GX XVI platforms.

7

S&M would be included for all GX XVI platforms placed in the price per test.

8

Cepheid’s pricing for all GX assays indicated above include distributor margin when tests are prepaid (payment made in full before goods are shipped), in all countries except Myanmar.

9

If the 30,000 test/instrument annual average cannot be met, Hologic has a separate pricing model that may be applicable for certain eligible countries.

10

This is a ceiling price associated with the volume commitment outlined above; lower prices may be accessed on a country-by-country basis.

11

Different prices may apply for special projects/grants, please contact Roche directly.

12

Abbott is in the process of revising the volume tiers and establishing global base prices with committed volumes for HIV, HBV and HCV tests. Please confirm updates with supplier.

13

Each GX XVI placement requires an annual purchase of 10,000 tests (of any corresponding assay listed except SARS-CoV-2) spread across all GeneXpert systems in the participating country.

14

Specific incoterm to be decided based on negotiation.

15

Special all-inclusive pricing for Aptima HPV is enabled through a 1,000,000 annual test volume commitment under the Global Health Supply Chain – Procurement and Supply Management Project (GHSC-PSM).

16

Applicable to DAP incoterms only.

Molecular Diagnostic Pricing Database Data

Below is a tabled sheet of the data. The chart is defaulted to show the first ten entries, but you can use the provided dropdown and paging buttons to view more entries.

ASLM is not responsible for the integrity of the data included herein after data files have been exported.
Export Full Data

Diagnostic Pricing 1

wdt_ID Company Platforms Corresponding assays Access pricing - Volume commitment Access pricing - Price per test (USD) Access pricing - Incoterm Access pricing - Instrument purchased or placed Access pricing - Price per instrument, if purchased (USD) Agreement specifications - Time commitment Agreement specifications - Eligible countries Laboratory - Reagents and proprietary consumables Laboratory - Invalid results due to instrument errors Laboratory - Non-proprietary consumables Laboratory - Instrument placement Laboratory - Service and maintenance (S&M) Laboratory - S&M fee per instrument (if not included in price) Supply chain for tests - Distributor and local agent fees Supply chain for tests - Packaging Supply chain for tests - Loading from warehouse Supply chain for tests - Pre-carriage Supply chain for tests - Export customs clearance Supply chain for tests - Handling at departure Supply chain for tests - Main transportation Supply chain for tests - Transportation insurance Supply chain for tests - Handling at arrival Supply chain for tests - Post-carriage Supply chain for tests - Duties and local taxes Supply chain for tests - Import customs clearance Supply chain for tests - Unloading at destination Additional resources and references

Molecular Diagnostic Pricing Database Data

Below is a tabled sheet of the data. The chart is defaulted to show the first ten entries, but you can use the provided dropdown and paging buttons to view more entries.

ASLM is not responsible for the integrity of the data included herein after data files have been exported.
Export Full Data

Diagnostic Pricing 2

wdt_ID Company Platforms Photo of platform Integrated kit/ separate reagents Batch controls Instrument portability Level of automation Max daily throughput inlcuding controls (Tests/8hr; 24hr) Sample loading Sample processing Time to first result (hrs)

*Multiple RT-PCR modules independently process cartridges

*The analyzer performs any requested sample in any sequence